Newsroom
Sorted by: Latest
-
Samenvatting: Guardant Health en Policlinico Gemelli lanceren eigen testdienst voor vloeibare biopsieën in Italië
PALO ALTO, Calif. & ROME--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), een toonaangevend bedrijf in precisie-oncologie, heeft vandaag de succesvolle lancering aangekondigd van FPG 360, een eigen testdienst voor vloeibare biopsieën bij de Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Policlinico Gemelli) in Rome, Italië. Deze samenwerking is de nieuwste in een reeks publiek-private samenwerkingen die Guardant Health is aangegaan met vooraanstaande Europese academische en o...
-
BW LPG Limited – Ex Dividend US$0.40 on the Oslo Stock Exchange Today
SINGAPORE--(BUSINESS WIRE)--With reference to the press release dated 2 December 2025 by BW LPG Limited (“BW LPG” or the “Company”, OSE ticker code: “BWLPG.OL”, NYSE ticker code “BWLP”) on key information relating to the cash dividend for Q3 2025, the shares of the Company will be traded ex-dividend on the Oslo Stock Exchange from today and from 12 December 2025 on the New York Stock Exchange. About BW LPG BW LPG is the world’s leading owner and operator of LPG vessels, owning and operating a f...
-
Innate Pharma Releases Its 2026 Financial Calendar
MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today released its 2026 financial calendar: March 26, 2026: Publication of 2025 financial statements May 13, 2026: Publication of revenue and cash position for 1Q2026 May 21, 2026: Annual General Shareholders Meeting September 17, 2026: Publication of half year financial statements November 5, 2026: Publication of revenue and cash position for 3Q2026 All financia...
-
Galderma Announces First Patient Enrollment in Study to Assess Nemolizumab in Adults With Chronic Pruritus of Unknown Origin
ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the first patient enrollment for its phase II study investigating the efficacy and safety of nemolizumab in treating patients living with Chronic Pruritus of Unknown Origin (CPUO). The first patient of the trial – which is taking place in the United States – was enrolled at Dr. Vlada Groysman’s site in Birmingham, Alabama. CPUO is an underdiagnosed condition defined as itch lastin...
-
Innate Pharma publie son calendrier financier pour 2026
MARSEILLE--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») publie aujourd’hui son calendrier financier pour l’année 2026 : 26 mars 2026 : Publication des résultats annuels 2025. 13 mai 2026 : Publication du chiffre d’affaires et de la position de trésorerie au premier trimestre 2026. 21 mai 2026 : Assemblée générale annuelle. 17 septembre 2026 : Publication des résultats semestriels 2026. 5 novembre 2026 : Publication du c...
-
Mitsubishi Electric Named to CDP’s Climate and Water “A List” for the 8th Time and 3rd Consecutive Year
TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today that the international nonprofit CDP has once again given Mitsubishi Electric its highest “A List” rankings for both Climate Change and Water Security activities. The top ratings recognize the environmental focus of Mitsubishi Electric’s commercial activities and goals as well as the company’s timely and appropriate information disclosure. Mitsubishi Electric has been named to the A List eight times in both ca...
-
Zilch Lands FCA Payments Licence Marking Major Strategic Growth Milestone
LONDON--(BUSINESS WIRE)--Today, Zilch, the consumer payments platform powering the future of commerce, has announced that it has secured a payments services licence from the Financial Conduct Authority (FCA), further cementing its position as a trusted leader within the market. The licensing marks a significant milestone for Zilch, removing the reliance on third-parties and enabling the business to build more payments methods in-house, develop and bring new products to market even faster and in...
-
New survey reveals how older Brits are determined to dodge winter viruses to protect their independence and loved ones
WALTON OAKS--(BUSINESS WIRE)--Pfizer Ltd today shared findings from a survey developed and funded by Pfizer but conducted independently by OnePoll, with 2,000 people aged over 65 across the UK between 21-27 November 2025, which reveals how older adult respondents see avoiding respiratory infections (COVID, pneumonia, RSV, flu) as essential to protecting both their freedom and their role at the heart of family and community life.1 The survey underscores the strong motivation older adult responde...
-
Azafaros Further Strengthens Its Board of Directors With Appointment of Biotech Entrepreneur Dr. Thierry Abribat
LEIDEN, Netherlands--(BUSINESS WIRE)--Azafaros strengthens board of directors with appointment of biotech entrepreneur Dr. Thierry Abribat...
-
Antin to Acquire NorthC, a Leading European Enterprise Colocation Data Centre Platform, From DWS
PARIS & LONDON & NEW YORK--(BUSINESS WIRE)--Regulatory News: Antin Infrastructure Partners (Paris:ANTIN) has agreed to acquire NorthC Datacenters, a leading enterprise colocation data centre platform in Northwest Europe, from DWS and other minority shareholders. The transaction is being carried out through Antin’s Flagship Fund V. Based in Amsterdam, NorthC operates 25 colocation data centres across major metropolitan areas in the Netherlands, Germany and Switzerland. The platform has more than...